Intangible Assets, Net

12 Months Ended

Dec. 31, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

At December 31, 2021, intangible assets, net consisted of the following (in thousands):


	Useful Life (Years)	Gross January 1, 2021		Additions		Impairment/ Disposal		Gross December 31, 2021		Accumulated Amortization		Net December 31, 2021
Indefinite lived assets:
Trademarks	N/A	$	—	$	2,150	$	—	$	2,150	$	—	$	2,150
Amortized intangible assets:
Network relationships	11-15	143,930		6,749		—		150,679		(84,865)		65,814
Management contracts	15	22,832		—		—		22,832		(13,563)		9,269
Member relationships	12	6,696		2,301		—		8,997		(4,606)		4,391
Patient management platform	5	2,060		—		—		2,060		(1,682)		378
Tradename/trademarks	20	1,011		—		—		1,011		(206)		805
		$	176,529	$	11,200	$	—	$	187,729	$	(104,922)	$	82,807

At December 31, 2020, intangible assets, net consisted of the following (in thousands):


	Useful Life (Years)	Gross January 1, 2020		Additions		Impairment/ Disposal		Gross December 31, 2020		Accumulated Amortization		Net December 31, 2020
Amortized intangible assets:
Network relationships	11-15	$	143,930	$	—	$	—	$	143,930	$	(73,169)	$	70,761
Management contracts	15	22,832		—		—		22,832		(11,715)		11,117
Member relationships	12	6,696		—		—		6,696		(3,234)		3,462
Patient management platform	5	2,060		—		—		2,060		(1,270)		790
Tradename/trademarks	20	1,011		—		—		1,011		(156)		855
		$	176,529	$	—	$	—	$	176,529	$	(89,544)	$	86,985

As of December 31, 2021, network relationships, management contracts, member relationships, patient management platform, and tradename/trademarks had weighted-average remaining useful lives of 10.5 years, 8.5 years, 8.3 years, 0.9 years, and 15.9 years, respectively. Amortization expense was $15.4 million, $16.0 million and $16.3 million for the years ended December 31, 2021, 2020, and 2019, respectively, which is included in depreciation and amortization in the accompanying consolidated statements of income.

During the year ended December 31, 2019, the Company wrote off indefinite-lived intangible assets of $2.0 million related to Medicare licenses it acquired as part of the 2017 Merger. The Company will no longer utilize these licenses and as such the Company will not receive future economic benefits. There was no impairment loss recorded related to intangibles for the year ended December 31, 2021 and 2020.

Future amortization expense is estimated to be as follows for the years ending December 31 (in thousands):


	Amount

2022	$	13,708
2023	11,661
2024	10,596
2025	9,414
2026	8,370
Thereafter	26,908
	$	80,657